Suzanne Borgel

1.3k total citations
23 papers, 902 citations indexed

About

Suzanne Borgel is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Suzanne Borgel has authored 23 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Suzanne Borgel's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Cells and Metastasis (4 papers) and Cancer therapeutics and mechanisms (4 papers). Suzanne Borgel is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer Cells and Metastasis (4 papers) and Cancer therapeutics and mechanisms (4 papers). Suzanne Borgel collaborates with scholars based in United States, Malaysia and Ukraine. Suzanne Borgel's co-authors include Melinda G. Hollingshead, John Carter, Robert H. Shoemaker, Giovanni Melillo, Carrie Bonomi, Luke H. Stockwin, Dianne L. Newton, Annamaria Rapisarda, Badarch Uranchimeg and Edward A. Sausville and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Suzanne Borgel

23 papers receiving 879 citations

Peers

Countries citing papers authored by Suzanne Borgel

Since Specialization

Citations

This map shows the geographic impact of Suzanne Borgel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Borgel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Borgel more than expected).

Fields of papers citing papers by Suzanne Borgel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Borgel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Borgel. The network helps show where Suzanne Borgel may publish in the future.

Co-authorship network of co-authors of Suzanne Borgel

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Borgel. A scholar is included among the top collaborators of Suzanne Borgel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Borgel. Suzanne Borgel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture 2023 ·Frontiers in Oncology ·(unknown), Harold N. Lovvorn, Melinda G. Hollingshead, Janene Pierce, Howard Stotler, Andrew J. Murphy, Suzanne Borgel, (unknown), Hernán Correa, Alan O. Perantoni	1
2	F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd 2021 ·Molecular Cancer Therapeutics ·Joel Morris, Donn G. Wishka, Omar D. Lopez, (unknown), (unknown), (unknown), Suzanne Borgel, (unknown), John Carter, Howard Stotler, Mark W. Kunkel, Jerry M. Collins, Melinda G. Hollingshead, Beverly A. Teicher	7
3	Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells 2018 ·PLoS ONE ·Tony Navas, Thomas D. Pfister, Simona Colantonio, (unknown), Lynda Dieckman, Richard G. Saul, Jan Kaczmarczyk, Suzanne Borgel, Sergio Y. Alcoser, Melinda G. Hollingshead, Young Ho Lee, Donald P. Bottaro, Tara Hiltke, Gordon Whiteley, Naoko Takebe, Robert J. Kinders, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow	9
4	Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays 2016 ·Clinical Cancer Research ·Apurva K. Srivastava, Melinda G. Hollingshead, Jennifer Weiner, Tony Navas, Yvonne A. Evrard, Sonny Khin, (unknown), Yiping Zhang, Suzanne Borgel, Thomas D. Pfister, Robert J. Kinders, Donald P. Bottaro, W. Marston Linehan, Joseph E. Tomaszewski, James H. Doroshow, Ralph E. Parchment	24
5	Abstract 5082: Impact of HGF knockin microenvironment on epithelial-mesenchymal transition and cancer stem cells in a non-small cell lung cancer xenograft model 2015 ·Cancer Research ·Tony Navas, Thomas D. Pfister, Scott M. Lawrence, Apurva K. Srivastava, Robert J. Kinders, Suzanne Borgel, Sergio Y. Alcoser, Melinda G. Hollingshead, (unknown), (unknown), Donna Butcher, (unknown), Naoko Takebe, Young Ho Lee, Donald P. Bottaro, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow	1
6	Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies 2014 ·BMC Genomics ·Melinda G. Hollingshead, Luke H. Stockwin, Sergio Y. Alcoser, Dianne L. Newton, Benjamin C. Orsburn, Carrie Bonomi, Suzanne Borgel, (unknown), (unknown), Elizabeth Hager, Susan L. Holbeck, Gurmeet Kaur, (unknown), Mark W. Kunkel, (unknown), Michael E. Mullendore, Howard Stotler, Jerry M. Collins	26
7	Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues 2012 ·PLoS ONE ·Thomas D. Pfister, Melinda G. Hollingshead, Robert J. Kinders, Yiping Zhang, Yvonne A. Evrard, Jiuping Ji, Sonny Khin, Suzanne Borgel, Howard Stotler, John Carter, (unknown), Shivaani Kummar, Yves Pommier, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow	13
8	ASPS-1, A Novel Cell Line Manifesting Key Features of Alveolar Soft Part Sarcoma 2011 ·Journal of Pediatric Hematology/Oncology ·Susan Kenney, David T. Vistica, Luke H. Stockwin, Sandra Burkett, Melinda G. Hollingshead, Suzanne Borgel, Donna Butcher, David S. Schrump, Robert H. Shoemaker	17
9	Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts 2011 ·BMC Biotechnology ·Sergio Y. Alcoser, (unknown), Suzanne Borgel, John Carter, (unknown), Melinda G. Hollingshead	52
10	Abstract 5202: Human colon cancer cell lines contain subsets of cells with the capacity to initiate highly prolific clonal growth in soft agar culture and to form transplantable tumor xenografts in vivo 2011 ·Cancer Research ·Michael C. Alley, Melinda G. Hollingshead, Suzanne Borgel, (unknown), (unknown), Miriam R. Anver, (unknown), Karen M. Hite, Dominic A. Scudiero, Anne Monks, Susan D. Mertins, Robert H. Shoemaker, John E. Niederhuber	1
11	Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC 2010 ·International Journal of Cancer ·Luke H. Stockwin, (unknown), Suzanne Borgel, Chad N. Hancock, Tracy Wolfe, Lawrence R. Phillips, Melinda G. Hollingshead, Dianne L. Newton	136
12	Therapeutic Vulnerability of an In Vivo Model of Alveolar Soft Part Sarcoma (ASPS) to Antiangiogenic Therapy 2009 ·Journal of Pediatric Hematology/Oncology ·David T. Vistica, Melinda G. Hollingshead, Suzanne Borgel, Susan Kenney, Luke H. Stockwin, Mark Raffeld, David S. Schrump, Sandra Burkett, Gary Stone, Donna Butcher, Robert H. Shoemaker	33
13	Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition 2009 ·Molecular Cancer Therapeutics ·Annamaria Rapisarda, Melinda G. Hollingshead, Badarch Uranchimeg, Carrie Bonomi, Suzanne Borgel, John Carter, Bradley Gehrs, Mark Raffeld, Robert J. Kinders, Ralph E. Parchment, Miriam R. Anver, Robert H. Shoemaker, Giovanni Melillo	136
14	Evidence of in vivo efficacy for the indenoisoquinolines linked with pharmacodynamic markers for γH2AX 2007 ·Molecular Cancer Therapeutics ·Melinda G. Hollingshead, Suzanne Borgel, John Carter, Carrie Bonomi, (unknown), Howard Stotler, (unknown), Nathaniel H. Greenberg, Gurmeet Kaur, Yves Pommier, (unknown), Ralph E. Parchment, Robert J. Kinders, Joseph E. Tomaszewski, James H. Doroshow	1
15	In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative 2005 ·Cancer Chemotherapy and Pharmacology ·Melinda G. Hollingshead, Michael C. Alley, Angelika M. Burger, Suzanne Borgel, (unknown), Heinz‐Herbert Fiebig, Edward A. Sausville	123
16	A potential role for imaging technology in anticancer efficacy evaluations 2004 ·European Journal of Cancer ·Melinda G. Hollingshead, Carrie Bonomi, Suzanne Borgel, (unknown), Robert H. Shoemaker, Giovanni Melillo, E. A. Sausville	31
17	Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts 2004 ·Cancer Research ·Annamaria Rapisarda, (unknown), Melinda G. Hollingshead, Till Braunschweig, Badarch Uranchimeg, Carrie Bonomi, Suzanne Borgel, John Carter, Stephen M. Hewitt, Robert H. Shoemaker, Giovanni Melillo	162
18	"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. 2003 ·PubMed ·Susanna M. Rybak, (unknown), Melinda G. Hollingshead, Suzanne Borgel, Dianne L. Newton, Giovanni Melillo, Dehe Kong, Gurmeet Kaur, Edward A. Sausville	42
19	In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model 1999 ·Bioorganic & Medicinal Chemistry Letters ·Ze‐Qi Xu, Melinda G. Hollingshead, Suzanne Borgel, (unknown), Albert Khilevich, Michael T. Flavin	45
20	Efficacy, Pharmacokinetics, and in Vivo Antiviral Activity of UC781, a Highly Potent, Orally Bioavailable Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1 1997 ·AIDS Research and Human Retroviruses ·Robert W. Buckheit, (unknown), Sherman F. Stinson, Valerie Fliakas-Boltz, Luke A. Pallansch, J. Alan Roberson, Walter J. Decker, (unknown), Suzanne Borgel, Carrie Bonomi, (unknown), (unknown), Louis Malspeis, John P. Bader	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact